Successful allogeneic hematopoietic stem cell transplantation for chronic granulomatous disease with inflammatory complications and severe infection

International Journal of Hematology

Volumn 94, Issue 5, 2011, Pages 479-482

  Kato, Keisuke ^a   Kojima, Yasuko ^a,e   Kobayashi, Chie ^a   Mitsui, Kazumasa ^a,e   Nakajima Yamaguchi, Ryoko ^a,d   Kudo, Kazuko ^a,d,f   Yanai, Toshihiro ^a   Yoshimi, Ai ^a   Nakao, Tomohei ^a   Morio, Tomohiro ^b   Kasahara, Mureo ^c   Koike, Kazutoshi ^a   Tsuchida, Masahiro ^a  

^a Ibaraki Children's Hospital   (Japan)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^c NATIONAL CENTER FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

^d UNIVERSITY OF TSUKUBA   (Japan)

^e TOHO UNIVERSITY OMORI MEDICAL CENTER   (Japan)

^f SHIZUOKA CHILDREN'S HOSPITAL   (Japan)

Author keywords

Aspergillus lung infection; Chronic granulomatous disease; Granulomatous colitis; Hematopoietic stem cell transplantation

Indexed keywords

AMPHOTERICIN; ANTIBIOTIC AGENT; BILIRUBIN; CYCLOSPORIN; GANCICLOVIR; GLYCOPROTEIN GP 91; MESALAZINE; METHOTREXATE; TACROLIMUS; THYMOCYTE ANTIBODY;

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; BACTERIUM CULTURE; CASE REPORT; CHILD; CHIMERA; CHRONIC GRANULOMATOUS DISEASE; COLITIS; COLON BIOPSY; COMPUTER ASSISTED TOMOGRAPHY; CONTINUOUS INFUSION; CREATININE CLEARANCE; CYTOMEGALOVIRUS INFECTION; DIARRHEA; DIET THERAPY; DISEASE ASSOCIATION; FEVER; FLOW CYTOMETRY; GRAFT REJECTION; GRAFT VERSUS HOST REACTION; HEMOLYTIC ANEMIA; HEPATOMEGALY; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERLIPIDEMIA; IMMUNOSUPPRESSIVE TREATMENT; LABORATORY TEST; LUNG ASPERGILLOSIS; MALE; NITROBLUE TETRAZOLIUM TEST; PANCREATITIS; PRESCHOOL CHILD; PROTEIN EXPRESSION; SCHOOL CHILD; STAPHYLOCOCCUS INFECTION; TREATMENT OUTCOME; WHOLE BODY RADIATION;

CHILD; CROHN DISEASE; GRANULOMATOUS DISEASE, CHRONIC; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LIVER ABSCESS; LUNG DISEASES, OBSTRUCTIVE; MALE; PULMONARY ASPERGILLOSIS; SEVERITY OF ILLNESS INDEX; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 84255214317     PISSN: 09255710     EISSN: 18653774     Source Type: Journal    
DOI: 10.1007/s12185-011-0932-6     Document Type: Article

References (18)

1. Dinauer MC. Chronic granulomatous disease and other disorders of phagocyte function. Hematology 2005:89-95.
2. RA Seger T Gungor BH Belohradsky S Blanche P Bordigoni, et al. 2002 Treatment of chronic granulomatous disease with myeloablative conditioning and an unmodified hemopoietic allograft: a survey of the European experience, 1985-2000 Blood 100 4344 4350 12393596 10.1182/blood-2002-02-0583 1:CAS:528:DC%2BD38XpsFCqs7g%3D (Pubitemid 35429672)
3. ME Horwitz AJ Barrett MR Brown CS Carter R Childs, et al. 2001 Treatment of chronic granulomatous disease with nonmyeloablative conditioning and a T-cell-depleted hematopoietic allograft N Engl J Med 344 881 888 11259721 10.1056/NEJM200103223441203 1:STN:280:DC%2BD3M7msVKgsA%3D%3D (Pubitemid 32224396)
4. S Yokoyama M Kasahara A Fukuda S Sato T Mori A Nakagawa A Matsui 2008 Successful living-donor liver transplantation for chronic hepatic graft-versus-host disease after bone marrow transplantation for chronic granulomatous disease Transplantation 86 367 368 18645505 10.1097/TP. 0b013e31817c16eb
5. MG Ott M Schmidt K Schwarzwaelder, et al. 2006 Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1 Nat Med 12 401 409 16582916 10.1038/nm1393 1:CAS:528:DC%2BD28XjtFKjtbg%3D
6. SH Parikh P Szabolcs VK Prasad S Lakshminarayanan PL Martin TA Driscoll J Kurtzberg 2007 Correction of chronic granulomatous disease after second unrelated-donor umbilical cord blood transplantation Pediatr Blood Cancer 49 982 984 17941061 10.1002/pbc.21365 (Pubitemid 350022456)
7. JA Nicholson RF Wynn TF Carr AM Will 2004 Sequential reduced- and full-intensity allografting using same donor in a child with chronic granulomatous disease and coexistent, significant comorbidity Bone Marrow Transplant 34 1009 1010 15489863 10.1038/sj.bmt.1704729 1:STN:280: DC%2BD2crnsVWksQ%3D%3D (Pubitemid 39600123)
8. I Del Giudice AP Iori A Mengarelli, et al. 2003 Allogeneic stem cell transplant from HLA-identical sibling for chronic granulomatous disease and review of the literature Ann Hematol 82 189 192 12634956 1:STN:280: DC%2BD3s7hvFyjtw%3D%3D (Pubitemid 36701004)
9. P Ljungman M Hassan AN Békássy O Ringdén G Oberg 1995 Busulfan concentration in relation to permanent alopecia in recipients of bone marrow transplants Bone Marrow Transplant 15 869 871 7581083 1:STN:280:DyaK28%2Fot1OisA%3D%3D
10. F Locatelli G Giorgiani A Pession M Bozzola 1993 Late effects in children after bone marrow transplantation: a review Haematologica. 78 319 328 8314162 1:STN:280:DyaK2c7kvVejtA%3D%3D (Pubitemid 23357441)
11. O Ringdén M Remberger T Ruutu, et al. 1999 Increased risk of chronic graft-versus-host disease, obstructive bronchiolitis, and alopecia with busulfan versus total body irradiation: long-term results of a randomized trial in allogeneic marrow recipients with leukemia. Nordic Bone Marrow Transplantation Group Blood 93 2196 2201 10090927 (Pubitemid 29153620)
12. RA Clift J Radich FR Appelbaum, et al. 1999 Long-term follow-up of a randomized study comparing cyclophosphamide and total body irradiation with busulfan and cyclophosphamide for patients receiving allogenic marrow transplants during chronic phase of chronic myeloid leukemia Blood 94 3960 3962 10627126 1:CAS:528:DyaK1MXnslyrsr4%3D
13. S Akioka H Itoh I Ueda, et al. 1998 Donor lymphocyte infusion at unstable mixed chimerism in an allogeneic BMT recipient for chronic granulomatous disease Bone Marrow Transplant 22 609 611 9758355 10.1038/sj.bmt.1701394 1:STN:280:DyaK1cvivFehsA%3D%3D (Pubitemid 28445767)
14. T Güngör J Halter A Klink S Junge KD Stumpe R Seger U Schanz 2005 Successful low toxicity hematopoietic stem cell transplantation for high-risk adult chronic granulomatous disease patients Transplantation. 79 1596 1606 15940051 10.1097/01.TP.0000163466.73485.5E (Pubitemid 40847593)
15. A Bacigalupo K Ballen D Rizzo, et al. 2009 Defining the intensity of conditioning regimens: working definitions Biol Blood Marrow Transplant 15 1628 1633 19896087 10.1016/j.bbmt.2009.07.004
16. A Nagler A Ackerstein J Kapelushnik R Or E Naparstek S Slavin 1999 Donor lymphocyte infusion post-non-myeloablative allogeneic peripheral blood stem cell transplantation for chronic granulomatous disease Bone Marrow Transplant 24 339 342 10455377 10.1038/sj.bmt.1701903 1:STN:280:DyaK1MzpsVOmsg%3D%3D (Pubitemid 29377878)
17. J Sastry A Kakakios H Tugwell PJ Shaw 2006 Allogeneic bone marrow transplantation with reduced intensity conditioning for chronic granulomatous disease complicated by invasive Aspergillus infection Pediatr Blood Cancer 47 327 329 16628555 10.1002/pbc.20865 (Pubitemid 44148051)
18. K Hara T Kajiume T Kondo Y Sera H Kawaguchi M Kobayashi 2009 Respiratory complications after haematopoietic stem cell transplantation in a patient with chronic granulomatous disease Transfus Med 19 105 108 19320854 10.1111/j.1365-3148.2009.00909.x 1:STN:280:DC%2BD1MzgtVKltw%3D%3D